J&J files lung cancer bispecific amivantamab for FDA approvalJohnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big Share XJ&J files lung cancer bispecific amivantamab for FDA approvalhttps://pharmaphorum.com/news/jj-files-lung-cancer-bispecific-amivantamab-for-fda-approval/
